about
α-Synuclein is a Novel Microtubule Dynamase.Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro.hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts.Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.Linking microtubules to Parkinson's disease: the case of parkin.Tools for the rational design of bivalent microtubule-targeting drugs.Correction: Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts.Parkin absence accelerates microtubule aging in dopaminergic neurons.AtFer4 ferritin is a determinant of iron homeostasis in Arabidopsis thaliana heterotrophic cells.Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for LSSRP1-mediated histone H1 eviction promotes replication origin assembly and accelerated developmentThe imbalance between dynamic and stable microtubules underlies neurodegeneration induced by 2,5-hexanedioneA Highly Luminescent Tetrahydrocurcumin IrIII Complex with Remarkable Photoactivated Anticancer Activity
P50
Q30811315-08A802E1-6635-4665-9E72-49F4A16A6D69Q33590557-384D04E3-FACA-4E20-8BB8-96A830AD3000Q34126568-CEE1A930-6334-4019-B589-A63D89E6366FQ34253625-D19AF039-2D9C-40CE-BBDD-50D2EF33435AQ34292484-6CEA92A5-A41E-4929-B7E9-A73DB85ADAD5Q36983909-E4DDE35C-E08E-4F02-9C0D-5E2A7043F2ACQ37287461-A2182738-E527-42F9-AD0D-6A307B5AC300Q38409508-69483CB3-6193-4BD9-8710-EA28F9A46005Q39405460-2399ED67-5D27-43AC-9D3D-E315DEE9A892Q45798476-7D69087F-B307-4FE8-BBC5-A6ECB0F7027FQ50081281-F6BD17DF-7F35-4001-AB3B-A18CA38A2DCCQ54414807-0B669E0D-1349-4A4E-BB8A-C08CB4348E55Q60655522-A0975788-0BCD-4695-B2F9-761E78769460Q90282003-C1FFAA51-54E9-4A22-BEF9-B26688A92DBAQ91042709-B2087A6C-60C3-4A4D-A855-C87BDEA3B3E7Q93092145-E454C5D7-D4B5-497A-9688-5CE99D3CAD3B
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2093-1393
@en
name
Francesca Casagrande
@ast
Francesca Casagrande
@en
Francesca Casagrande
@es
Francesca Casagrande
@nl
type
label
Francesca Casagrande
@ast
Francesca Casagrande
@en
Francesca Casagrande
@es
Francesca Casagrande
@nl
prefLabel
Francesca Casagrande
@ast
Francesca Casagrande
@en
Francesca Casagrande
@es
Francesca Casagrande
@nl
P106
P108
P31
P496
0000-0002-2093-1393